Study flags need to monitor frailty risks with GLP-1 drugs for older adults - Reuters
Study flags need to monitor frailty risks with GLP-1 drugs for older adults Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxPUU1ZX1Zfd0F3c1A5M0ZuNktDa3MzY0xMZklnTEN3cjdqam5CWWpTM2tHamp3YXhFMjVPSm43SlFweUk2R3RuS1FJa1A0WUFtSTNVUlYxWjdRb2RXSmczOW1fUDBkcTNPVWZlR29ocThIWnFpUnhCX09LYVVqLTFQc1RjRHI3WFlwYjIzVVU2aEhOa1JBRlNoV2pnVWRoTFM3YXJYYXFJcUhoYXZTd1ZpSmRwX3NKT05kM3Vqc3FR?oc=5" target="_blank">Study flags need to monitor frailty risks with GLP-1 drugs for older adults</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight - Reuters
WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight Reuters
October 7, 2026 at 07:39 AMPepsiCo running out of time to meet Elliott-inspired targets as GLP-1 threat intensifies - Reuters
PepsiCo running out of time to meet Elliott-inspired targets as GLP-1 threat intensifies Reuters
October 7, 2026 at 11:36 AMUS FDA flags four deaths in Newron's schizophrenia drug studies - Reuters
US FDA flags four deaths in Newron's schizophrenia drug studies Reuters
October 8, 2026 at 05:47 PMUS FDA expands use of Novartis drug for chronic skin condition - Reuters
US FDA expands use of Novartis drug for chronic skin condition Reuters
October 7, 2026 at 04:51 PMArgenx discontinues Vyvgart study in Sjögren's disease, shares tumble - Reuters
Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble Reuters
October 8, 2026 at 08:49 PMMost Medicare Advantage drug plan enrollees in high-quality plans, US government says - Reuters
Most Medicare Advantage drug plan enrollees in high-quality plans, US government says Reuters
October 8, 2026 at 11:29 PM